The US Government via the FDA has now outlined via its Regulatory Policy that it is serious about Regenerative Medicine and Cell Therapy.
After more than 10 years of medical trials, I believe Mesoblast has a role to play in this field of medicine.
Their niche will be the autoimmune/immunomodulatory component of the human body.
In particular the fight against reducing inflammation and regeneration via MSC's
Sure money has been spent and capital has been raised but the future is here and real and Governments are now recognising this and giving the GREEN LIGHT!
FDA announce new policy approach, page-11
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.105(8.37%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.14 | $9.583M | 8.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |